Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/TCRM.S313003 http://scihub22266oqcxt.onion/10.2147/TCRM.S313003 34234442!8254585!34234442     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ther+Clin+Risk+Manag 2021 ; 17 (ä): 657-668 Nephropedia Template TP {{tp|p=34234442|t=2021. Therapeutic Agents Rounding Up the Immunopathology of COVID-19 |pdf=|usr=}}{{34234442}} gab.com Text Therapeutic Agents Rounding Up the Immunopathology of COVID-19 JO: Ther Clin Risk Manag http://www.kidney.de/pget.php?&tw=1&pmid=34234442 #FOAvip COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause "cytokine storm", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 therapy, and several agents targeting immunopathology, including interferons, thymosin, glucocorticoids and immunoglobulin, have shown therapeutic effects in severe patients with COVID-19. Herein, we reviewed the practice evidences and concluded that several agents rounding up the immunopathology of COVID-19 may be the alternative approaches under the scenario of the lacking of effective antiviral drugs. Twit Text FOAVip Therapeutic Agents Rounding Up the Immunopathology of COVID-19 ????Ther Clin Risk Manag http://www.kidney.de/pget.php?&tw=1&pmid=34234442 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34234442 #FOAvip English Wikipedia <ref>{{Cite pmid|34234442}}</ref> Therapeutic Agents Rounding Up the Immunopathology of COVID-19 #MMPMID34234442 Li HP; He X; Zhang L; Li CX; Li SQ; Li QY Ther Clin Risk Manag 2021[]; 17 (ä): 657-668 PMID34234442show ga COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause "cytokine storm", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 therapy, and several agents targeting immunopathology, including interferons, thymosin, glucocorticoids and immunoglobulin, have shown therapeutic effects in severe patients with COVID-19. Herein, we reviewed the practice evidences and concluded that several agents rounding up the immunopathology of COVID-19 may be the alternative approaches under the scenario of the lacking of effective antiviral drugs. äTherapeutic Agents Rounding Up the Immunopathology of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing